Additionally, increased non-adipose tissue-derived FABP-4 secretion may also contribute to increased circulating levels observed in our study and our finding of increased FABP-4 mRNA in lung tissue from patients with IPAH supports this notion. The gene discussed is FABP4; the disease is idiopathic pulmonary arterial hypertension.